CASQ1
protein-codingcalsequestrin 1, the group of Protein disulfide isomerases
Gene summary
This gene encodes the skeletal muscle specific member of the calsequestrin protein family. Calsequestrin functions as a luminal sarcoplasmic reticulum calcium sensor in both cardiac and skeletal muscle cells. This protein, also known as calmitine, functions as a calcium regulator in the mitochondria of skeletal muscle. This protein is absent in patients with Duchenne and Becker types of muscular dystrophy. [provided by RefSeq, Jun 2013]
- CASQ
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~11.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0014546
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0008051
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0014546
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Musculoskeletal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CASQ1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001231.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 81 | 1 | 85 | ||
| missense | 2 | 2 | 180 | 11 | 3 | 198 |
| nonsense | 1 | 11 | 12 | |||
| start loss | 1 | 1 | 2 | |||
| frameshift | 1 | 12 | 13 | |||
| splice donor/acceptor (+/-2bp) | 1 | 9 | 2 | 12 | ||
| Total | 2 | 5 | 216 | 95 | 4 | 322 |
Highest pathogenic variant AF is 0.0000371779
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001222.3 | 11 | MANE Select | |
| Ensembl | ENSP00000357057.3 | 11 | MANE Select | |
| Ensembl | ENSP00000418051.1 | 4 | Standard | |
| Ensembl | ENSP00000418051.1 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Antiarrhythmic Pathway, Pharmacodynamics
- Calcium Regulation in the Cardiac Cell
Biological Process
- endoplasmic reticulum organization
- skeletal muscle tissue development
- response to heat
- response to organic substance
- regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion
Molecular Function
- calcium ion binding
- protein binding
- identical protein binding
Cellular Component
- mitochondrion
- mitochondrial matrix
- endoplasmic reticulum
- smooth endoplasmic reticulum
- Golgi apparatus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000368078
- Coding exons
- 11
- Length
- 11392
- Individuals with no LoFs
- 125440
- Homozygous LoFs
- 2
- Heterozygous LoFs
- 306
- Defined
- 125748
- p
- 0.00123
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.0187 | 226 | 225 | 1.00 | 0.0000120 | 2640 |
| Missense (PolyPhen) | 64 | 71.781 | 0.8916 | 895 | ||
| Synonymous | 0.957 | 83 | 94.9 | 0.875 | 0.00000613 | 710 |
| Loss of Function | -0.570 | 25 | 22.1 | 1.13 | 0.00000112 | 258 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00055 | 0.00055 | rare |
| Latino/Admixed American | 0.00035 | 0.00035 | rare |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.0016 | 0.0016 | notable |
| Finnish | 0.00079 | 0.00079 | rare |
| European (Non-Finnish) | 0.0018 | 0.0018 | notable |
| South Asian | 0.00082 | 0.00078 | rare |
| Other | 0.0011 | 0.0011 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Calsequestrin is a high-capacity, moderate affinity, calcium-binding protein and thus acts as an internal calcium store in muscle (PubMed:28895244). Calcium ions are bound by clusters of acidic residues at the protein surface, often at the interface between subunits. Can bind around 80 Ca(2+) ions (PubMed:28895244). Regulates the release of lumenal Ca(2+) via the calcium release channel RYR1; this plays an important role in triggering muscle contraction. Negatively regulates store-operated Ca(2+) entry (SOCE) activity (PubMed:27185316). {ECO:0000269|PubMed:22337878, ECO:0000269|PubMed:27185316, ECO:0000269|PubMed:28895244, ECO:0000303|PubMed:22337878}.;
- Disease
- DISEASE: Myopathy, vacuolar, with CASQ1 aggregates (VMCQA) [MIM:616231]: An autosomal dominant mild muscle disorder characterized by adult onset of muscle cramping and weakness as well as increased levels of serum creatine kinase. The disorder is not progressive, and some patients may be asymptomatic. {ECO:0000269|PubMed:25116801, ECO:0000269|PubMed:26136523, ECO:0000269|PubMed:27196359, ECO:0000269|PubMed:28895244}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, tubular aggregate, 1 (TAM1) [MIM:160565]: A rare congenital myopathy characterized by regular arrays of membrane tubules on muscle biopsies without additional histopathological hallmarks. Tubular aggregates in muscle are structures of variable appearance consisting of an outer tubule containing either one or more microtubule-like structures or amorphous material. They may occur in a variety of circumstances, including inherited myopathies, alcohol- and drug-induced myopathies, exercise-induced cramps or muscle weakness. {ECO:0000269|PubMed:28895244}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.201
Intolerance Scores
- LoFtool
- 0.733
- RVIS EVS
- 0.6
- RVIS percentile EVS
- 82.74
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.598
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |